Pandion Therapeutics Inc’s $135 Million Initial Public Offering

Ambrogio Visconti

Goodwin Procter LLP advised the Goldman Sachs & Co. LLC, Morgan Stanley, SVB Leerink and BMO Capital Markets. Pandion Therapeutics, Inc., a clinical-stage biotechnology company developing…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now